The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.
(clink on the link below to read the full paper)
www.beat-leukemia.org
Fondazione Beat Leukemia Dr Alessandro Cevenini - CF 94618790151 | Legal Notices | Realizzazione sito web: Progetto Web